Full List of Protein(s) Regulated by This Metabolite |
Acetate uptake transporter (AceTr) |
Dyads accumulation 2 (ADY2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
ADY2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of ADY2 protein expression compared with control group. |
Actin (ACT) |
Actin beta (ACTB) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
ACTB protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of ACTB protein expression compared with control group. |
Beta actin like protein 2 (ACTBL2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
ACTBL2 protein expression levels: increase (FC = 4) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of ACTBL2 protein expression compared with control group. |
Beta centractin (ACTR1B) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
ACTR1B protein expression levels: increase (FC = 4) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of ACTR1B protein expression compared with control group. |
Smooth muscle gamma-actin (ACTG2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
ACTG2 protein expression levels: increase (FC = 4) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of ACTG2 protein expression compared with control group. |
Amino acid/polyamine transporter (AAPT) |
Solute carrier family 38 member 2 (SLC38A2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SLC38A2 protein abundance levels: decrease (FC = 1.50) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of SLC38A2 protein abundance compared with control group. |
Solute carrier family 38 member 4 (SLC38A4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SLC38A4 protein abundance levels: decrease (FC = 2.55) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of SLC38A4 protein abundance compared with control group. |
Annexin (ANEX) |
Annexin A6 (ANXA6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
ANXA6 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of ANXA6 protein expression compared with control group. |
ATP-binding cassette transporter (ABCT) |
ATP-binding cassette F3 (ABCF3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
ABCF3 protein abundance levels: increase (FC = 1.50) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of ABCF3 protein abundance compared with control group. |
B-cell translocation gene (BTG) |
B-cell translocation gene 1 (BTG1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
BTG1 protein expression levels: increase (FC = 4) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of BTG1 protein expression compared with control group. |
Basement-membrane protein (BMP) |
Osteonectin (SPARC) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SPARC protein abundance levels: increase (FC = 2.08) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of SPARC protein abundance compared with control group. |
Cadherin (CAD) |
Protocadherin gamma-A4 (PCDHGA4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
PCDHGA4 protein abundance levels: decrease (FC = 1.64) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of PCDHGA4 protein abundance compared with control group. |
Calcium-binding protein (CBP) |
Reticulocalbin-3 (RCN3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
RCN3 protein abundance levels: increase (FC = 1.56) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of RCN3 protein abundance compared with control group. |
Stromal cell-derived factor 4 (SDF4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SDF4 protein abundance levels: increase (FC = 3.05) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of SDF4 protein abundance compared with control group. |
Cell division cycle protein (CDC) |
Cell division cycle protein 123 (CDC123) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
CDC123 protein abundance levels: increase (FC = 1.53) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of CDC123 protein abundance compared with control group. |
Cell division cycle protein 20 (CDC20) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
CDC20 protein abundance levels: decrease (FC = 1.97) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of CDC20 protein abundance compared with control group. |
Chaperone protein (ChaP) |
Heat shock protein 40 (HSP40) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
DNAJB1 protein abundance levels: increase (FC = 1.84) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of DNAJB1 protein abundance compared with control group. |
Hsp90 co-chaperone Cdc37 (CDC37) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
CDC37 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose decrease causes the increase of PKLR protein expression compared with control group. |
Mitochondrial 10kDa heat shock protein (HSPE1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
HSP10 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of HSP10 protein expression compared with control group. |
Coiled-coil containing (CCC) |
Kinetochore protein Spc24 (SPC24) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SPC24 protein abundance levels: increase (FC = 1.56) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of SPC24 protein abundance compared with control group. |
Short coiled-coil protein (SCOC) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SCOC protein abundance levels: increase (FC = 1.87) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of SCOC protein abundance compared with control group. |
Tropomyosin-1 (TPM1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (24 hours) |
Induced Change |
TPM1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of TPM1 protein expression compared with control group. |
X-linked lymphocyte-regulated protein PM1 (XLR) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
XLR protein abundance levels: increase (FC = 3.26) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of XLR protein abundance compared with control group. |
ZW10 interactor (ZWINT) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
ZWINT protein abundance levels: increase (FC = 1.51) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of ZWINT protein abundance compared with control group. |
Cyclin-related protein (CRP) |
Caprin-1 (RNG105) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
CAPRIN1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of CAPRIN1 protein expression compared with control group. |
Cyclin-dependent kinase regulatory 2 (CKS2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
CKS2 protein abundance levels: increase (FC = 1.56) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of CKS2 protein abundance compared with control group. |
G1/S-specific cyclin-D1 (CCND1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
CCND1 protein abundance levels: increase (FC = 1.57) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of CCND1 protein abundance compared with control group. |
Cysteine-rich secretory (CRS) |
Glioma pathogenesis-related protein 2 (GLIPR2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
GLIPR2 protein abundance levels: increase (FC = 1.68) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of GLIPR2 protein abundance compared with control group. |
Cytochrome (Cyt) |
Cytochrome C isoform 1 (CYC1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
CYC1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of CYC1 protein expression compared with control group. |
Cytochrome oxidase (CytOx) |
Complex I-MLRQ (NDUFA4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
NDUFA4 protein abundance levels: decrease (FC = 1.53) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of NDUFA4 protein abundance compared with control group. |
Cytochrome reductase (CytRe) |
Ubiquinol-cytochrome c oxidoreductase 6 (QCR6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
QCR6 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of QCR6 protein expression compared with control group. |
Cytoskeleton-associated protein (CytoA) |
Syntenin-1 (SDCBP) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SDCBP protein abundance levels: increase (FC = 2.03) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of SDCBP protein abundance compared with control group. |
Developmental protein (DevP) |
Protein CUSTOS (CUSTOS) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
CUSTOS protein abundance levels: increase (FC = 1.69) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of CUSTOS protein abundance compared with control group. |
DNA binding protein (DNBP) |
DNA damage-binding protein 1 (DDB1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
DDB1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of DDB1 protein expression compared with control group. |
Endothelial differentiation factor 1 (EDF1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
EDF1 protein abundance levels: increase (FC = 2.07) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of EDF1 protein abundance compared with control group. |
Meiosis protein 5 homolog (MEI5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SFR1 protein abundance levels: increase (FC = 1.81) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of SFR1 protein abundance compared with control group. |
Pumilio homolog 3 (PUM3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
PUM3 protein abundance levels: decrease (FC = 1.65) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of PUM3 protein abundance compared with control group. |
Endopeptidase enhancer (EDEH) |
Procollagen C-endopeptidase enhancer 1 (PCOLCE) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
PCOLCE protein abundance levels: increase (FC = 3.34) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of PCOLCE protein abundance compared with control group. |
Eutherian X-chromosome-specific (Armcx) |
Armadillo repeat X-linked 2 (ARMCX2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
ARMCX2 protein abundance levels: increase (FC = 2.62) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of ARMCX2 protein abundance compared with control group. |
Fatty acid transporter (FAT) |
Long-chain-fatty-acid-CoA ligase 2 (FAA2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
FAA2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of FAA2 protein expression compared with control group. |
Fibrillar collagen (FC) |
Alpha-1 type I collagen (COL1A1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
COL1A1 protein abundance levels: increase (FC = 2.38) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of COL1A1 protein abundance compared with control group. |
Collagen I (COL1A2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
COL1A2 protein abundance levels: increase (FC = 1.98) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of COL1A2 protein abundance compared with control group. |
Fibronectin (FibNe) |
Fibronectin (FN1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
FN1 protein abundance levels: increase (FC = 1.91) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of FN1 protein abundance compared with control group. |
Membrane glycoprotein 130 (GP130) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
IL6ST protein abundance levels: increase (FC = 1.57) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of IL6ST protein abundance compared with control group. |
Fibulin (Fibu) |
EGF-containing fibulin-like matrix 2 (EFEMP2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
EFEMP2 protein abundance levels: increase (FC = 3.14) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of EFEMP2 protein abundance compared with control group. |
Globin (Glo) |
Hemoglobin alpha (HBA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
HBA protein abundance levels: decrease (FC = 2.14) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of HBA protein abundance compared with control group. |
Hemoglobin beta-2 chain (HBB-B2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
HBB-B2 protein abundance levels: decrease (FC = 2.29) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of HBB-B2 protein abundance compared with control group. |
GPCR rhodopsin (GPCR-1) |
GPCR84 receptor (GPR84) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[5] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
GPR84 mRNA levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Diabetes mellitus [ICD-11: 5A14]
|
Details |
It is reported that glucose addition causes the increase of GPR84 mRNA levels compared with control group. |
Growth arrest-specific protein (GASP) |
Growth arrest-specific protein 1 (GAS1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
GAS1 protein abundance levels: increase (FC = 1.90) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of GAS1 protein abundance compared with control group. |
Growth factor (GF) |
Fibroblast growth factor-4 (FGF4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] |
Introduced Variation |
Glucose decrease (36 hours) |
Induced Change |
FGF4 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose decrease causes the decrease of FGF4 protein expression compared with control group. |
Phosphatidylinositol glycan anchor biosynthesis F (PIGF) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] |
Introduced Variation |
Glucose decrease (36 hours) |
Induced Change |
PIGF protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose decrease causes the decrease of PIGF protein expression compared with control group. |
Growth factor receptor binding protein (GFRBP) |
Growth factor receptor-bound protein 10 (GRB10) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
GRB10 protein abundance levels: increase (FC = 1.52) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of GRB10 protein abundance compared with control group. |
Guanine nucleotide binding protein (GNBP) |
G protein gamma 10 (GNG10) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
GNG10 protein abundance levels: increase (FC = 1.51) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of GNG10 protein abundance compared with control group. |
Heat shock protein (HSP) |
Heat shock protein 26 (HSP26) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
HSP26 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of HSP26 protein expression compared with control group. |
Heat shock protein 90 beta (HSP90B) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
HSP90AB1 protein expression levels: decrease (FC = 4) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the decrease of HSP90AB1 protein expression compared with control group. |
Hydrolases (EC 3) |
Acetyl-CoA hydrolase (ACH1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
ACH1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of ACH1 protein expression compared with control group. |
Carboxypeptidase Q (CPQ) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
CPQ protein abundance levels: decrease (FC = 1.57) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of CPQ protein abundance compared with control group. |
Cathepsin D (CTSD) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
CTSD protein expression levels: decrease (FC = 4) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the decrease of CTSD protein expression compared with control group. |
Cathepsin L (CTSL) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
CTSL protein abundance levels: increase (FC = 1.82) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of CTSL protein abundance compared with control group. |
DEAD-box RNA helicase PRP5 (RNA5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (24 hours) |
Induced Change |
PRP5 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of PRP5 protein expression compared with control group. |
Endochitinase (CTS1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
CTS1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of CTS1 protein expression compared with control group. |
Invertase 2 (SUC2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
SUC2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of SUC2 protein expression compared with control group. |
L-glutamine amidohydrolase (GLS) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
GLS protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of GLS protein expression compared with control group. |
Lipopolysaccharide-associated 1 (HSPA8) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
HSPA8 protein expression levels: decrease (FC = 4) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the decrease of HSPA8 protein expression compared with control group. |
Matrix metalloproteinase-14 (MMP-14) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
MMP14 protein abundance levels: decrease (FC = 1.53) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of MMP14 protein abundance compared with control group. |
Phosphoinositide 3-phosphatase (YMR1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
YMR1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of YMR1 protein expression compared with control group. |
Phosphoserine phosphatase (PSPH) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
PSPH protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glucose decrease causes the increase of PSPH protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
PSPH mRNA levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glucose decrease causes the increase of PSPH mRNA levels compared with control group. |
Ribonuclease P (RPM2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
RPM2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of RPM2 protein expression compared with control group. |
SRAP domain-containing protein 1 (SRAPD1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
HMCES protein abundance levels: decrease (FC = 1.61) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of HMCES protein abundance compared with control group. |
Ubiquitin carboxyl-terminal hydrolase 3 (USP3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
USP3 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of USP3 protein expression compared with control group. |
Immunoglobulin (IMG) |
MHC class II antigen DOA (HLA-DOA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
HLA-DOA protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of HLA-DOA protein expression compared with control group. |
TGF-beta-1-binding protein (CD109) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
CD109 protein abundance levels: increase (FC = 1.62) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of CD109 protein abundance compared with control group. |
ULP1-interacting protein 4 (UIP4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (24 hours) |
Induced Change |
UIP4 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of UIP4 protein expression compared with control group. |
Interferon (IF) |
Interferon-beta (IFNB1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glucose decrease (4 hours) |
Induced Change |
IFNB1 mRNA levels: increase (FC = 2) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Acute lymphoblastic leukemia [ICD-11: 2B33]
|
Details |
It is reported that glucose decrease causes the increase of IFNB1 mRNA levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glucose decrease (4 hours) |
Induced Change |
IFNB1 mRNA levels: increase (FC = 2) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Acute lymphoblastic leukemia [ICD-11: 2B33]
|
Details |
It is reported that glucose decrease causes the increase of IFNB1 mRNA levels compared with control group. |
Isomerases (EC 5) |
Inositol-3-phosphate synthase (INO1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
INO1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of INO1 protein expression compared with control group. |
Matrix protein P1 (HSPD1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
HSPD1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of HSPD1 protein expression compared with control group. |
Phosphoglucomutase 1 (PGM1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
PGM1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of PGM1 protein expression compared with control group. |
Phosphoglycerate mutase 1 (PGAM1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
PGAM1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of PGAM1 protein expression compared with control group. |
Triosephosphate isomerase (TPI1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
TPI1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of TPI1 protein expression compared with control group. |
Ligases (EC 6) |
Acetyl-coenzyme A synthetase 1 (ACS1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
ACS1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of ACS1 protein expression compared with control group. |
Leucyl-tRNA synthetase (CDC60) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
CDC60 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of CDC60 protein expression compared with control group. |
Phenylalanine-tRNA ligase beta (FARSB) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
FARSB protein expression levels: increase (FC = 4) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of FARSB protein expression compared with control group. |
Lyases (EC 4) |
Alpha-enolase (ENO1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
ENO1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of ENO1 protein expression compared with control group. |
Fructose-bisphosphate aldolase B (ALDOB) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
ALDOB protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of ALDOB protein expression compared with control group. |
Homoaconitate hydratase (LYS4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (24 hours) |
Induced Change |
LYS4 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of LYS4 protein expression compared with control group. |
Peroxisomal hydratase-dehydrogenase-epimerase (FOX2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
FOX2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of FOX2 protein expression compared with control group. |
tRNA-splicing endonuclease Sen15 (TSEN15) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
TSEN15 protein abundance levels: increase (FC = 1.55) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of TSEN15 protein abundance compared with control group. |
Macroglobulin (MGL) |
Complement C4-B (C4B) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
C4B protein abundance levels: increase (FC = 2.09) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of C4B protein abundance compared with control group. |
MORF4-associated protein (MAP) |
MORF4 family-associated protein 1 (MRFAP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
MRFAP1 protein abundance levels: increase (FC = 2.29) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of MRFAP1 protein abundance compared with control group. |
Myosin-kinesin (MK) |
Centromeric protein E (CENPE) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
CENPE protein abundance levels: increase (FC = 1.87) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of CENPE protein abundance compared with control group. |
Nmyc downstream regulated gene (NDRG) |
Differentiation-related gene 1 protein (NDRG1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
NDRG1 protein abundance levels: increase (FC = 2.62) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of NDRG1 protein abundance compared with control group. |
Nuclear envelope organisation (NEO) |
Meiotic sister chromatid recombination 1 (MSC1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
MSC1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of MSC1 protein expression compared with control group. |
Nuclear hormone receptor (NHR) |
PPAR-gamma (PPARG) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Glucose decrease (4 hours) |
Induced Change |
PPARG protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Myocardial infarction [ICD-11: BA41]
|
Details |
It is reported that glucose decrease causes the increase of PPARG protein expression compared with control group. |
Nuclear migration protein (NMP) |
Nuclear migration protein JNM1 (JNM1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
JNM1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of JNM1 protein expression compared with control group. |
Nucleolar GTP-binding (NGB) |
Nucleolar GTP-binding protein 2 (GNL2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
GNL2 protein abundance levels: decrease (FC = 1.78) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of GNL2 protein abundance compared with control group. |
Nucleolar/spindle-associated (NSA) |
Nucleolar/spindle-associated 1 (NUSAP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
NUSAP1 protein abundance levels: decrease (FC = 1.77) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of NUSAP1 protein abundance compared with control group. |
Nucleotide exchange factor (NEF) |
Hsp70-binding protein 1 (HSPBP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
HSPBP1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the decrease of HSPBP1 protein expression compared with control group. |
Oxidoreductases (EC 1) |
Acyl-coenzyme A oxidase (POX1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
POX1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of POX1 protein expression compared with control group. |
Alcohol dehydrogenase 2 (ADH2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
ADH2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of ADH2 protein expression compared with control group. |
Alcohol dehydrogenase 5 (ADH5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
ADH5 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of ADH5 protein expression compared with control group. |
Cyclooxygenase-2 (COX-2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
PTGS2 protein abundance levels: decrease (FC = 1.60) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of PTGS2 protein abundance compared with control group. |
Cytosolic malate dehydrogenase (MDH1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
MDH1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of MDH1 protein expression compared with control group. |
Dehydrogenase/reductase SDR 1 (DHRS1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
DHRS1 protein abundance levels: increase (FC = 1.95) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of DHRS1 protein abundance compared with control group. |
ERO1-like protein alpha (ERO1A) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
ERO1A protein abundance levels: increase (FC = 2.76) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of ERO1A protein abundance compared with control group. |
Fatty acid desaturase 3 (FADS3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
FADS3 protein abundance levels: increase (FC = 1.99) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of FADS3 protein abundance compared with control group. |
Frataxin homolog (YFH1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
YFH1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of YFH1 protein expression compared with control group. |
Glyceraldehyde-3-phosphate dehydrogenase 1 (GAPDH) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
GAPDH protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of GAPDH protein expression compared with control group. |
Glycerol-3-phosphate dehydrogenase (GPD-M) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
GUT2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of GUT2 protein expression compared with control group. |
Heme oxygenase 1 (HMOX1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
HMOX1 protein abundance levels: increase (FC = 3.43) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of HMOX1 protein abundance compared with control group. |
L-lactate dehydrogenase B chain (LDHB) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
LDHB protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of LDHB protein expression compared with control group. |
Lactate dehydrogenase A (LDHA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
LDHA protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of LDHA protein expression compared with control group. |
Lysine-specific demethylase 4A (KDM4A) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
KDM4A protein abundance levels: increase (FC = 1.78) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of KDM4A protein abundance compared with control group. |
Lysyl hydroxylase 1 (PLOD1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
PLOD1 protein abundance levels: increase (FC = 1.62) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of PLOD1 protein abundance compared with control group. |
Lysyl hydroxylase 2 (LH2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
PLOD2 protein abundance levels: increase (FC = 2.83) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of PLOD2 protein abundance compared with control group. |
Lysyl oxidase (LOX) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
LOX protein abundance levels: increase (FC = 4.25) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of LOX protein abundance compared with control group. |
Lysyl oxidase homolog 3 (LOXL3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
LOXL3 protein abundance levels: increase (FC = 2.11) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of LOXL3 protein abundance compared with control group. |
Mitochondrial cytochrome b2 (CYB2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
CYB2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of CYB2 protein expression compared with control group. |
NAD-dependent formate dehydrogenase 2 (FDH2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (24 hours) |
Induced Change |
FDH2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of FDH2 protein expression compared with control group. |
NADH-ubiquinone oxidoreductase 1 (NDE1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
NDE1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of NDE1 protein expression compared with control group. |
NADP-dependent malic enzyme (ME1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
ME1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of ME1 protein expression compared with control group. |
NADPH-dependent alpha-keto amide reductase (YDL124W) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
YDL124W protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of YDL124W protein expression compared with control group. |
Oxalosuccinate decarboxylase (IDP2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
IDP2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of IDP2 protein expression compared with control group. |
Peroxisomal catalase A (CTA1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
CTA1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of CTA1 protein expression compared with control group. |
Peroxisomal malate dehydrogenase (MDH3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
MDH3 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of MDH3 protein expression compared with control group. |
Phosphoglycerate dehydrogenase (PHGDH) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
PHGDH protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of PHGDH protein expression/PHGDH mRNA levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
PHGDH mRNA levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of PHGDH mRNA levels compared with control group. |
Potassium-activated aldehyde dehydrogenase (ALD4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
ALD4 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of ALD4 protein expression compared with control group. |
Prolyl 4-hydroxylase alpha-2 (P4HA2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
P4HA2 protein abundance levels: increase (FC = 1.59) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of P4HA2 protein abundance compared with control group. |
Short-chain specific acyl-CoA dehydrogenase (ACADS) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Glucose decrease (4 hours) |
Induced Change |
ACADS protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Myocardial infarction [ICD-11: BA41]
|
Details |
It is reported that glucose decrease causes the increase of ACADS protein expression compared with control group. |
Sulfide quinone oxidoreductase (SQOR) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SQOR protein abundance levels: increase (FC = 2.05) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of SQOR protein abundance compared with control group. |
Perilipin (PELIP) |
Perilipin-2 (PLIN2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
PLIN2 protein abundance levels: increase (FC = 2.05) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of PLIN2 protein abundance compared with control group. |
Peroxisomal pore-forming (Pex11) |
Peroxisomal membrane protein PMP27 (PEX11) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
PEX11 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of PEX11 protein expression compared with control group. |
Pleckstrin (Plec) |
Pleckstrin homology-like domain family A member 3 (PHLDA3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
PHLDA3 protein abundance levels: increase (FC = 2.57) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of PHLDA3 protein abundance compared with control group. |
Prokineticin (Prok) |
Prokineticin-1 (PROK1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] |
Introduced Variation |
Glucose decrease (36 hours) |
Induced Change |
PROK1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose decrease causes the decrease of PROK1 protein expression compared with control group. |
Protease inhibitor I9 (I9) |
Protease B inhibitor 2 (PBI2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
PBI2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of PBI2 protein expression compared with control group. |
Protein 4F5-related (PFR) |
Small EDRK-rich factor 2 (SERF2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SERF2 protein abundance levels: increase (FC = 2.31) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of SERF2 protein abundance compared with control group. |
Ras-related protein (RASR) |
Ras association domain-containing protein 1 (RASSF1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
RASSF1 protein abundance levels: decrease (FC = 1.84) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of RASSF1 protein abundance compared with control group. |
Rho-binding protein (RBDP) |
Cdc42 effector protein 2 (CEP2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
CDC42EP2 protein abundance levels: increase (FC = 2.84) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of CDC42EP2 protein abundance compared with control group. |
Ribosomal protein (Ribo) |
L-name-related protein 42 (LNR42) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
NSA2 protein abundance levels: decrease (FC = 2.23) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of NSA2 protein abundance compared with control group. |
Ribosomal protein L7-like 1 (RPL7L1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
RPL7L1 protein abundance levels: decrease (FC = 1.79) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of RPL7L1 protein abundance compared with control group. |
RNA polymerase (RNPol) |
DNA-directed RNA polymerase II RPB3 (POLR2C) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
POLR2C protein abundance levels: increase (FC = 1.66) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of POLR2C protein abundance compared with control group. |
DNA-directed RNA polymerase II RPB7 (POLR2G) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
POLR2G protein abundance levels: increase (FC = 1.53) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of POLR2G protein abundance compared with control group. |
DNA-directed RNA polymerase II RPB9 (POLR2I) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
POLR2I protein abundance levels: increase (FC = 2.22) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of POLR2I protein abundance compared with control group. |
DNA-directed RNA polymerase III RPC8 (POLR3H) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
POLR3H protein abundance levels: increase (FC = 1.64) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of POLR3H protein abundance compared with control group. |
RNA recognition motif (Rnrmo) |
Cold-inducible RNA-binding (CIRBP) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
CIRBP protein abundance levels: increase (FC = 2.45) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of CIRBP protein abundance compared with control group. |
Nuclear localization sequence-binding protein (NSR1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
NSR1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of NSR1 protein expression compared with control group. |
Polymerase delta-interacting protein 3 (POLDIP3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
POLDIP3 protein abundance levels: increase (FC = 1.98) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of POLDIP3 protein abundance compared with control group. |
RNA-binding protein (RBP) |
Glycolysis regulation protein 3 (GCR3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
STO1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of STO1 protein expression compared with control group. |
RNA-binding protein PNO1 (PNO1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
PNO1 protein abundance levels: decrease (FC = 1.64) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of PNO1 protein abundance compared with control group. |
Serpin (Serp) |
Pigment epithelium-derived factor (SERPINF1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SERPINF1 protein abundance levels: increase (FC = 2.00) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of SERPINF1 protein abundance compared with control group. |
Sodium:neurotransmitter symporter (SNF) |
Sodium/chloride-dependent transporter taurine (SLC6A6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SLC6A6 protein abundance levels: decrease (FC = 1.71) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of SLC6A6 protein abundance compared with control group. |
Somatotropin (Soma) |
Prolactin-2C2 (PRL2C2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
PRL2C2 protein abundance levels: decrease (FC = 4.82) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of PRL2C2 protein abundance compared with control group. |
Sugar transporter (ST) |
HepG2 glucose transporter (SLC2A1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SLC2A1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of SLC2A1 protein expression compared with control group. |
Hexose transporter HXT6 (HXT6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
HXT6 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of HXT6 protein expression compared with control group. |
TCP-1 chaperonin (TCP-1C) |
HIV-1 Nef-interacting protein (CCT7) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
T-complex protein 1 subunit alpha isoform a protein expression levels: decrease (FC = 4) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the decrease of T-complex protein 1 subunit alpha isoform a protein expression compared with control group. |
Thioredoxin (ThReDo) |
Thioredoxin domain-containing protein 15 (TXNDC15) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
TXNDC15 protein abundance levels: increase (FC = 1.68) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of TXNDC15 protein abundance compared with control group. |
Thrombospondin (ThRoPo) |
Thrombospondin-1 (THBS1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
THBS1 protein abundance levels: decrease (FC = 1.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of THBS1 protein abundance compared with control group. |
Thymosin (Thym) |
Thymosin beta-10 (TMSB10) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
TMSB10 protein abundance levels: increase (FC = 1.54) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of TMSB10 protein abundance compared with control group. |
Transcription factor (TF) |
Homeobox protein Rhox5 (PEM) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
RHOX5 protein abundance levels: increase (FC = 2.13) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of RHOX5 protein abundance compared with control group. |
Leucine-rich repeat-containing 58 (LRRC58) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
LRRC58 protein abundance levels: increase (FC = 1.64) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of LRRC58 protein abundance compared with control group. |
Transcription regulator (TR) |
Mortality factor 4-like protein 1 (MORF4L1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
MORF4L1 protein abundance levels: increase (FC = 1.95) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of MORF4L1 protein abundance compared with control group. |
Transferases (EC 2) |
Acetyl-CoA acyltransferase (FOX3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
POT1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of POT1 protein expression compared with control group. |
Adenylate kinase isoenzyme 6 (AK6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
AK6 protein abundance levels: increase (FC = 1.60) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of AK6 protein abundance compared with control group. |
Alpha-isopropylmalate synthase (LEU4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
LEU4 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of LEU4 protein expression compared with control group. |
Carnitine O-palmitoyltransferase 2 (CPT2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Glucose decrease (4 hours) |
Induced Change |
CPT2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Myocardial infarction [ICD-11: BA41]
|
Details |
It is reported that glucose decrease causes the increase of CPT2 protein expression compared with control group. |
Cytoplasmic aspartate aminotransferase (GOT1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
GOT1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of GOT1 protein expression compared with control group. |
Discoidin domain-containing receptor 2 (DDR2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
DDR2 protein abundance levels: increase (FC = 1.70) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of DDR2 protein abundance compared with control group. |
DNA-directed RNA polymerase II RPB1 (POLR2A) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
POLR2A protein abundance levels: increase (FC = 2.19) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of POLR2A protein abundance compared with control group. |
DNA-directed RNA polymerase II RPB2 (POLR2B) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
POLR2B protein abundance levels: increase (FC = 1.79) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of POLR2B protein abundance compared with control group. |
Epidermal growth factor receptor (EGFR) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glucose addition (150 hours) |
Induced Change |
EGFR protein abundance levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Brain cancer [ICD-11: 2A00]
|
Details |
It is reported that glucose addition causes the increase of EGFR protein abundance compared with control group. |
Fatty acid synthase (FASN) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Glucose decrease (4 hours) |
Induced Change |
FASN protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Myocardial infarction [ICD-11: BA41]
|
Details |
It is reported that glucose decrease causes the increase of FASN protein expression compared with control group. |
Glucokinase-1 (HOR3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
GLK1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of GLK1 protein expression compared with control group. |
Glucokinase-2 (EMI2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
EMI2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of EMI2 protein expression compared with control group. |
Glycogen synthase 1 (GYS1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
GYS1 protein abundance levels: increase (FC = 2.09) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of GYS1 protein abundance compared with control group. |
Glycogen-branching enzyme (GBE1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
GBE1 protein abundance levels: increase (FC = 1.68) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of GBE1 protein abundance compared with control group. |
Hexokinase-1 (HKA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
HXK1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of HXK1 protein expression compared with control group. |
Hexokinase-2 (HK2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
HK2 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the decrease of HK2 protein expression compared with control group. |
Janus kinase 1 (JAK-1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
JAK1 protein abundance levels: increase (FC = 1.80) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of JAK1 protein abundance compared with control group. |
Malate synthase 1 (MLS1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
MLS1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of MLS1 protein expression compared with control group. |
Nitric oxide synthase-interacting protein (NOSIP) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
NOSIP protein abundance levels: increase (FC = 1.53) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of NOSIP protein abundance compared with control group. |
O-linked N-acetylglucosamine transferase (OGT) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[10] |
Introduced Variation |
Glucose decrease (24 hours) |
Induced Change |
OGT protein phosphorylation levels: increase (FC = 5) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Bladder Cancer [ICD-11: 2C94]
|
Details |
It is reported that glucose decrease causes the increase of OGT protein phosphorylation compared with control group. |
Phosphofructo-1-kinase isozyme B (PFK-B) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
PFKL protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of PFKL protein expression compared with control group. |
Phosphoglycerate kinase 1 (PGK1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
PGK1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of PGK1 protein expression compared with control group. |
Phosphoinositide dependent protein kinase-1 (PDPK1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
PDPK1 protein abundance levels: increase (FC = 1.63) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of PDPK1 protein abundance compared with control group. |
Phosphoserine aminotransferase (PSAT1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
PSAT1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glucose decrease causes the increase of PSAT1 protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
PSAT1 mRNA levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glucose decrease causes the increase of PSAT1 mRNA levels compared with control group. |
Pyruvate kinase 1 (PKLR) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
PKLR protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glucose decrease causes the increase of PKLR protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
PKLR protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the decrease of PKLR protein expression compared with control group. |
RING finger protein 181 (RNF181) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
RNF181 protein abundance levels: increase (FC = 3.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of RNF181 protein abundance compared with control group. |
Serine hydroxymethyltransferase (SHMT2) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
SHMT2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glucose decrease causes the increase of SHMT2 protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
SHMT2 mRNA levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glucose decrease causes the increase of SHMT2 mRNA levels compared with control group. |
Serine methylase (SHMT1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
SHMT1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glucose decrease causes the increase of SHMT1 protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glucose decrease (48 hours) |
Induced Change |
SHMT1 mRNA levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glucose decrease causes the increase of SHMT1 mRNA levels compared with control group. |
Serine/threonine-protein kinase STE11 (STE11) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
STE11 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of STE11 protein expression compared with control group. |
Serine/threonine-protein kinase tousled-like 1 (TLK1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
TLK1 protein abundance levels: increase (FC = 1.70) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of TLK1 protein abundance compared with control group. |
Signal-regulated kinase 1 (ERK1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glucose addition (50 hours) |
Induced Change |
MAPK3 protein abundance levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Brain cancer [ICD-11: 2A00]
|
Details |
It is reported that glucose addition causes the increase of MAPK3 protein abundance compared with control group. |
Signal-regulated kinase 2 (ERK2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glucose addition (50 hours) |
Induced Change |
MAPK1 protein abundance levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Brain cancer [ICD-11: 2A00]
|
Details |
It is reported that glucose addition causes the increase of MAPK1 protein abundance compared with control group. |
SIK family kinase 3 (SIK3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
SIK3 protein abundance levels: increase (FC = 1.51) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of SIK3 protein abundance compared with control group. |
Stress-activated protein kinase 2a (p38 alpha) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glucose addition (50 hours) |
Induced Change |
MAPK14 protein abundance levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Brain cancer [ICD-11: 2A00]
|
Details |
It is reported that glucose addition causes the increase of MAPK14 protein abundance compared with control group. |
Thiosulfate:glutathione sulfurtransferase (RDL1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
RDL1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of RDL1 protein expression compared with control group. |
Trifunctional enzyme beta (HADHB) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Glucose decrease (4 hours) |
Induced Change |
HADHB protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Myocardial infarction [ICD-11: BA41]
|
Details |
It is reported that glucose decrease causes the increase of HADHB protein expression compared with control group. |
Tyrosine-protein kinase UFO (AXL) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
AXL protein abundance levels: increase (FC = 2.77) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of AXL protein abundance compared with control group. |
Uridine-cytidine kinase 2 (UCK2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
UCK2 protein abundance levels: increase (FC = 1.55) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of UCK2 protein abundance compared with control group. |
Translation initiation factor (TIF) |
Eukaryotic translation initiation factor 1A (EIF1A) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
EIF1 protein abundance levels: increase (FC = 1.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of EIF1 protein abundance compared with control group. |
Eukaryotic translation initiation factor 1B (EIF1B) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
EIF1B protein abundance levels: increase (FC = 2.07) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of EIF1B protein abundance compared with control group. |
Hypusine-containing protein HP2 (HYP2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
HYP2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of HYP2 protein expression compared with control group. |
Translocases (EC 7) |
Chromosome transmission fidelity 18 (CHTF18) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
CHTF18 protein abundance levels: increase (FC = 2.06) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of CHTF18 protein abundance compared with control group. |
Cytochrome C oxidase polypeptide III (MT-CO3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
MT-CO3 protein abundance levels: decrease (FC = 1.65) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of MT-CO3 protein abundance compared with control group. |
Transmembrane protein (TMEM) |
Growth and transformation-dependent protein (HGTD-P) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
FAM162A protein abundance levels: increase (FC = 1.79) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of FAM162A protein abundance compared with control group. |
Hypoxia-inducible gene 1 protein (HIG1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
HIGD1A protein abundance levels: increase (FC = 2.03) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of HIGD1A protein abundance compared with control group. |
Mitochondrial outer membrane protein OM45 (OM45) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (1.50 hours) |
Induced Change |
OM45 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of OM45 protein expression compared with control group. |
Ubiquitin/ubiquinone (UbiQ) |
NADH dehydrogenase [ubiquinone] 1 C2 (NDUFC2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
NDUFC2 protein abundance levels: increase (FC = 1.62) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of NDUFC2 protein abundance compared with control group. |
Vinculin/alpha-catenin (VAC) |
Vinculin (VCL) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glucose addition (16 hours) |
Induced Change |
VCL protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that glucose addition causes the increase of VCL protein expression compared with control group. |
WD repeat protein (WRP) |
DDB1/CUL4-associated factor 13 (DCAF13) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
DCAF13 protein abundance levels: decrease (FC = 1.56) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the decrease of DCAF13 protein abundance compared with control group. |
Zinc finger protein (ZIN) |
Uncharacterized protein YNL134C (YNL134C) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glucose addition (24 hours) |
Induced Change |
YNL134C protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glucose addition causes the increase of YNL134C protein expression compared with control group. |
Zinc finger protein 593 (ZNF593) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glucose (low concentration) addition (17.50 hours) |
Induced Change |
ZNF593 protein abundance levels: increase (FC = 1.89) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cerebral stroke [ICD-11: 8B11]
|
Details |
It is reported that low glucose addition causes the increase of ZNF593 protein abundance compared with control group. |
|
|
|
|
|
|
|